IMUX ▲ +1.4% - Immunic, Inc. $IMUX IMUX - Immunic to Present New Clinical, Biomarker and Preclinical Data on Vidofludimus Calcium at MSToronto2026 - the 10th Joint ACTRIMS-ECTRIMS Meeting 07-OCT-2026 08:01 AM ET